Order Article Reprints

Stocki P, Szary J, Demydchuk M, Northall L, Rasmussen CLM, Logan DB, Gauhar A, Thei L, Coker S-F, Moos T, et al. CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration. Pharmaceutics. 2023; 15(3):739. https://doi.org/10.3390/pharmaceutics15030739

Stocki, Pawel, Jaroslaw Szary, Mykhaylo Demydchuk, Leandra Northall, Charlotte L. M. Rasmussen, Diana Bahu Logan, Aziz Gauhar, Laura Thei, Shu-Fen Coker, Torben Moos, and et al. 2023. "CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration" Pharmaceutics 15, no. 3: 739. https://doi.org/10.3390/pharmaceutics15030739

Stocki, P., Szary, J., Demydchuk, M., Northall, L., Rasmussen, C. L. M., Logan, D. B., Gauhar, A., Thei, L., Coker, S.-F., Moos, T., Walsh, F. S., & Rutkowski, J. L. (2023). CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration. Pharmaceutics, 15(3), 739. https://doi.org/10.3390/pharmaceutics15030739